United Therapeutics pays $140M for thymic cell therapy startup
United Therapeutics pays $140M for thymic cell therapy startup — Fierce Biotech coverage of biopharma industry developments.
United Therapeutics
United Therapeutics is a biotechnology company focused on developing therapies for pulmonary arterial hypertension and other rare diseases.
Company Info
Sector:Biopharmaceutical
Headquarters:Silver Spring, Maryland, United States
Founded:1996
Website:www.unither.com/
Upcoming Milestones & Key Dates
2026-Q4
Business
Thymic cell therapy integration
Clinical Development Pipeline
Tyvaso
Target: ProstacyclinOrenitram
Target: ProstacyclinTymalor (oral treprostinil)
Target: ProstacyclinRecent News
Leadership Team
Martine Rothblatt
Chairperson and Chief Executive Officer
Michael Benkowitz
President and Chief Operating Officer
James Huang
Chief Financial Officer
Careers & Job Openings